ORMP
#3593
Oramed Pharmaceuticals Inc. - Common Stock
5.0 3 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.37%
Monthly Change
+25.75%
6 month change
+47.51%
Year Change
+135.05%
Previous Close
5.1 0
Open
5.0 3
Low
5.0 3
High
5.0 3
Volume
34
Financials
- Market Capitalization 209.23 M
- Employee 13
- Founded 2006
- CEO Nadav Kidron
- Website www.oramed.com
- Headquarter Delaware, United States
- FIGI BBG000LRYR36
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
1.9
Price to sales ratio
60.45
Dividends per share
0.25
Dividend yield %
8.77
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3591 |  ANTX AN2 Therapeutics, Inc. - Common Stock | 5.58 USD | -2.79% | -4.12% | +10.93% | +398.21% | 210.57 M USD | ||
| 3592 |  IMUX Immunic, Inc. - Common Stock | 15.40 USD | -5.52% | -6.55% | +18.46% | +1778.05% | 210.12 M USD | ||
| 3597 |  IPHA Innate Pharma S.A. - American Depositary Shares | 2.23 USD | 0.00% | +0.90% | +27.43% | +7.21% | 208.99 M USD | ||
| 3610 |  PLX Protalix BioTherapeutics, Inc. Common Stock | 2.53 USD | -3.07% | +6.75% | +11.45% | -13.36% | 203.85 M USD |
Frequently asked questions about Oramed Pharmaceuticals Inc.
What is the Oramed Pharmaceuticals Inc. stock price today?
The current price of Oramed Pharmaceuticals Inc. (ORMP) is 5.03. Over the past 24 hours, the stock has changed by -1.37%. Follow the ORMP chart for real-time price dynamics.
What is the stock ticker of Oramed Pharmaceuticals Inc.?
Oramed Pharmaceuticals Inc. trades under the ticker ORMP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Oramed Pharmaceuticals Inc. stock going up?
ORMP has changed by +4.57% over the last week, +25.75% over the last month, and +135.05% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Oramed Pharmaceuticals Inc.?
Oramed Pharmaceuticals Inc. currently has a market capitalization of 209.23 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Oramed Pharmaceuticals Inc. release financial reports?
Yes. You can track Oramed Pharmaceuticals Inc. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Oramed Pharmaceuticals Inc. earnings last quarter?
Last quarter, Oramed Pharmaceuticals Inc. reported earnings of 1.9 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Oramed Pharmaceuticals Inc. revenue for the last quarter?
Oramed Pharmaceuticals Inc. reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Oramed Pharmaceuticals Inc. net income for the last quarter?
Oramed Pharmaceuticals Inc. reported net income of 78.16 M for the last quarter. The previous quarter showed 38.31 M, which means net income changed by +104.01%.
How many employees does Oramed Pharmaceuticals Inc. have?
As of the latest available data, Oramed Pharmaceuticals Inc. has 13 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Oramed Pharmaceuticals Inc. stock?
You can buy Oramed Pharmaceuticals Inc. (ORMP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Oramed Pharmaceuticals Inc. stock?
Investing in Oramed Pharmaceuticals Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ORMP chart and related analysis on metatrader.com as part of your research.